Actively Recruiting

Age: 0 - 50Years
All Genders
ID06773546

Study of Immune System Disorders and Inborn Errors of Immunity in Children and Adults: Diagnostics and Management

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14

400

Participants Needed

1

Research Sites

171 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying Inborn Errors of Immunity, a group of inherited diseases caused by problems in the immune system's development or function. The study aims to better understand the clinical, immune system, functional, and genetic features of both children and adults diagnosed with or suspected to have these immune disorders. It focuses especially on patients showing signs of immune system regulation problems and tracks their clinical progress and immune system abnormalities. This observational study gathers information from patients treated under usual medical care. Evaluations include blood tests, detailed immune cell analysis, antibody levels, vaccine response assessments, detection of auto-antibodies, complement protein levels, imaging tests, immune function tests, and genetic testing targeting immune regulation and inherited immune errors. These assessments were done retrospectively and will continue prospectively to collect comprehensive data. Participants undergo evaluations at the start and continue to be monitored over time for immune system changes, infection susceptibility, immune dysregulation, and survival up to one year after diagnosis. Researchers measure various immune and clinical outcomes to understand disease impacts and progression. The study includes both pediatric and adult patients up to 50 years old with confirmed or suspected immune errors and follows their health and immune status over time.

CONDITIONS

Official Title

Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System Disorders

Who Can Participate

Age: 0 - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with confirmed or suspected Inborn Errors of Immunity
  • Age under 50 years at onset of symptoms suspected for Inborn Errors of Immunity
  • Informed consent obtained from patients or parents/legal guardians of pediatric patients
Not Eligible

You will not qualify if you...

  • Patients whose infection susceptibility and immune dysregulation are due only to known non-immunological causes
  • Acquired immunodeficiency secondary to chronic infections such as HIV
  • Acquired immunodeficiency secondary to immunosuppressive treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bolgona, Italy, 40138

Actively Recruiting

Loading map...

Research Team

F

Francesca Conti

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Safety and Evaluation of Cyclophosphamide and Ruxolitinib fo...

Inborn Errors of Immunity

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here